EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Japan Vietnam Medical Instrument JSC (JVC) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Japan Vietnam Medical Instrument JSC VND 2,362, price VND 2,720, upside -13.2%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · VN · ISIN VN000000JVC7

JV Thin data Sep 24, 2026

Japan Vietnam Medical Instrument JSC

JVC · VN

Weak valuationQuality is weak on top of the rich price.

!Fair value 2,362 VND · Overvalued (−13%)
!Quality 50/100
!Weak Growth (revenue YoY −4.9 %/yr)
!Thin margins · 5.0% net margin (TTM)
✓generates free cash flow
✓Ranks above peers (7/8)
!Narrow moat 39/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 16 out of 100
!Weak on past: 24 out of 100
Watch Japan Vietnam Medical Instrument JSC for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

13,450 VND 2,310 VND Fair Value 2,362 VND Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 2,310 VND – 13,450 VND · fair‑value band 2,109 VND – 2,844 VND · the 2,720 VND price screens above the 2,362 VND fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Japan Vietnam Medical Instrument JSC in your weekly email

Every Wednesday you see whether Japan Vietnam Medical Instrument JSC is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Vietnam Medical and Pharmaceutical Investment Joint Stock Company engages in the distribution of medical equipment and instruments in Vietnam.

Show more

Vietnam Medical and Pharmaceutical Investment Joint Stock Company engages in the distribution of medical equipment and instruments in Vietnam. The company distributes medical equipment, including diagnostic imaging products, such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray system, computed and direct radiography, dry imager, contrast injector, PET/CT imaging system, and diagnostic ultrasound products; washers, dryers, and sterilizers; and ultrasound systems, anesthesia and breathing machines, syringe and infusion pumps, and patient monitors, as well as navigation products. It also offers SD-S, DI-HT, SD-Q, and DI-HL dry medical films; central venous catheters and invasive blood pressure transducers for resuscitation-cardiovascular intervention; Scepter XC and C balloon, and Chaperon guiding catheters; LVIS Jr. and LVIS coil assist stents; and V-grip detachment controllers, Traxcess guidewires, Headway Duo microcatheters, ERIC retrieval devices, SOFIA PLUS aspiration and SOFIA intermediate catheters, FRED and FRED Jr. flow diversion devices, platinum and hydrogel coils, PHIL liquid embolics, and Headway microcatheters. In addition, the company provides technical services, such as consulting, technical support, repair, and maintenance services; and IT services for hospitals. Further, it leases medical equipment and instruments; operates general, specialist, and dental clinics; invests in medical equipment; and engages in the financial investment activities. Vietnam Medical and Pharmaceutical Investment Joint Stock Company was formerly known as Japan Vietnam Medical Investment and Development Joint Stock Company and changed its name to Vietnam Medical and Pharmaceutical Investment Joint Stock Company in November 2025. The company was founded in 2001 and is headquartered in Hanoi, Vietnam.

Stock analysis

Japan Vietnam Medical Instrument JSC (JVC) currently trades at 2,720 VND, while our model-based Fair Value estimate is 2,362 VND, implying the stock looks roughly 15.2% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 2,769 VND per share, and 6 of the 11 models we run sit above the 2,720 VND price.

Bear case: the Multiples group reads lowest at 2,419 VND, and 5 of the 11 models stay below the price. Evidence for this calculation is low.

Scenario range: 2,109 VND (bear) to 2,844 VND (bull), the price of 2,720 VND sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Japan Vietnam Medical Instrument JSC reported revenue of 391B VND in FY2022 versus 517B VND in FY2020, a compound −13.0%/yr. Reported net income was −29.9B VND in FY2022.

Key figures

Market cap 371B VND · P/S ratio 0.50 · EPS (TTM) −75.57 VND · Net margin −7.7% · Return on equity 6.0% · Return on assets (EBIT) −6.7% · Operating margin 11.9% · Revenue (TTM) 741B VND.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 70% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −13%, JVC screens richer than that median.

Fair Value models

Bear 2,109 VND Fair Value 2,362 VND Bull 2,844 VND
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 2,343 VND 2,769 VND 3,533 VND 73
Growth DCF 2,392 VND 2,803 VND 3,482 VND 70
Owner Earnings 3,310 VND 4,090 VND 5,488 VND 68
All 11 models by family
DCF Models
FCF DCF 2,343 VND 2,769 VND 3,533 VND 73
Owner Earnings 3,310 VND 4,090 VND 5,488 VND 68
5Y Revenue Exit 2,122 VND 2,503 VND 3,056 VND 65
5Y EBITDA Exit 3,835 VND 5,468 VND 7,631 VND 66
10Y Revenue Exit 2,181 VND 2,469 VND 2,771 VND 60
10Y EBITDA Exit 3,220 VND 4,261 VND 5,396 VND 61
Multiples
EV/EBITDA 5,440 VND 6,860 VND 8,280 VND 64
EV/Revenue 2,047 VND 2,419 VND 2,791 VND 52
Asset-Based
NCAV (Graham) 1,888 VND 2,530 VND 3,776 VND 51
Growth DCF
Growth DCF 2,392 VND 2,803 VND 3,482 VND 70
Rev-Margin DCF 2,122 VND 2,531 VND 3,039 VND 65

Open the full fair value analysis →

Notify me when JVC reaches fair value

Put JVC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 50/100

Of which business quality 48 · Market factors (momentum, volatility) 22

Profitability 11
Margins and returns on capital today
Quality Growth 63
Are margins and returns improving?
Cashflow 24
Earnings quality: real cash, not paper profit
Fin. Strength 67
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 66
Calm price path (market factor)
Momentum 7
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Vietnam: IMF forecast 4.1% a year to 2030, 3.1% from 2016 to 2025) that is about +13.3% a year for the price.

JVC screens 15% overvalued. Compare with Abbott Laboratories, →

Compare Japan Vietnam Medical Instrument JSC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks

Beats the industry median on 7/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 50 · Above median
Fair Value upside −14% · Above median
Profitability
Return on equity (TTM) 6% · Above median
Return on assets 3% · Above median
Net margin (TTM) 5% · Above median
Operating margin (TTM) 12% · Above median
Growth and dividend
Revenue growth −12% · Bottom 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)16 · sector 10
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)24 · sector 7
HEALTH (low debt)0 · sector 97
DIVIDEND (yield)0 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $103.49 $74.79 −28%
Stryker Corporation SYK $273.40 $300.74 +10%
Medtronic plc MDT $89.30 $65.57 −27%
Boston Scientific Corporation BSX $44.62 $49.08 +10%
Edwards Lifesciences Corporation EW $86.82 $82.04 −6%
Siemens Healthineers AG SHL €37.21 €35.22 −5%
DexCom, Inc DXCM $87.73 $96.50 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Japan Vietnam Medical Instrument JSC · Fair Value
2,362 VND −15%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Japan Vietnam Medical Instrument JSC Fair Value". https://www.fairvalue-calculator.com/stock/JVC

Frequently asked questions

Is Japan Vietnam Medical Instrument JSC (JVC) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 2,362 VND versus a price of 2,720 VND, about −13% upside (overvalued).
What is the fair value of JVC?
Our model-based fair value for Japan Vietnam Medical Instrument JSC is 2,362 VND (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,720 VND.
What is the quality score of JVC?
Japan Vietnam Medical Instrument JSC has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Japan Vietnam Medical Instrument JSC (JVC)?
Our model-based price target is the fair value of 2,362 VND (as of Sep 24, 2026) from 11 valuation models. Cautious scenario 2,109 VND, optimistic scenario 2,844 VND. It is a calculation from audited fundamentals, not an analyst target.
What is the Japan Vietnam Medical Instrument JSC stock forecast for 2026?
Our models put fair value at 2,362 VND, about −13% upside versus a price of 2,720 VND (overvalued). Cautious scenario 2,109 VND, optimistic scenario 2,844 VND. The calculation is refreshed regularly with new filings.
What is the revenue of Japan Vietnam Medical Instrument JSC (JVC)?
Japan Vietnam Medical Instrument JSC reported trailing-twelve-month revenue of about 741B VND (latest available figure, as of Sep 24, 2026).
What growth is priced into Japan Vietnam Medical Instrument JSC (JVC)?
For today's price to be fair in a discounted-cash-flow model, Japan Vietnam Medical Instrument JSC would have to grow free cash flow by +17.9 % per year for five years (discount rate 12.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew -13.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of JVC use?
Our models discount Japan Vietnam Medical Instrument JSC at 12.5 %: a base by market capitalisation (nano), damped by beta 0.74, country premium for Vietnam. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Japan Vietnam Medical Instrument JSC that is +17.9 % per year a year over ten years, using the same discount rate (12.5 %) and the same formula as our fair value.
How much growth has Japan Vietnam Medical Instrument JSC (JVC) delivered so far?
Over the past 2 years revenue at Japan Vietnam Medical Instrument JSC grew -13.0 % a year. The price currently implies +17.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Japan Vietnam Medical Instrument JSC (JVC) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Japan Vietnam Medical Instrument JSC (+17.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Japan Vietnam Medical Instrument JSC (JVC)?
The free-cash-flow yield on the price is 3.51 %: that much free cash flow Japan Vietnam Medical Instrument JSC produces per unit of market value. When it exceeds the discount rate of our models (12.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Japan Vietnam Medical Instrument JSC (JVC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Japan Vietnam Medical Instrument JSC it is 2,362 VND per share (as of Sep 24, 2026), against a price of 2,720 VND. It is the blended result of 11 valuation models (cash flow, earnings, asset, dividend).
Is Japan Vietnam Medical Instrument JSC stock overvalued or undervalued in 2026?
As of Sep 24, 2026, JVC trades above its calculated fair value: price 2,720 VND, fair value 2,362 VND, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of JVC?
No. The price is what the market pays today (2,720 VND); the fair value is what the company's own numbers justify (2,362 VND). For Japan Vietnam Medical Instrument JSC the two are 358.40 VND per share apart. That gap is exactly why we show both numbers side by side.
How much is Japan Vietnam Medical Instrument JSC worth?
The market values Japan Vietnam Medical Instrument JSC at about 371B VND (market capitalisation, as of Sep 24, 2026). Per share that is 2,720 VND; our models calculate a fair value of 2,362 VND per share.
What do the bullish and bearish scenarios say about JVC?
Our models span a range for Japan Vietnam Medical Instrument JSC: cautious scenario 2,109 VND, base 2,362 VND, optimistic 2,844 VND per share (as of Sep 24, 2026, price 2,720 VND). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Japan Vietnam Medical Instrument JSC (JVC)?
Balance-sheet figures for Japan Vietnam Medical Instrument JSC (as of Sep 24, 2026): return on equity 6.0%. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is JVC from its 52-week high?
Japan Vietnam Medical Instrument JSC trades at 2,720 VND, about 70% below its 52-week high of 9,000 VND and at the low of 2,720 VND (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 2,362 VND is for.
Which stocks are comparable to Japan Vietnam Medical Instrument JSC?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Japan Vietnam Medical Instrument JSC stock attractive at the current price?
The data as of Sep 24, 2026: price 2,720 VND, calculated fair value 2,362 VND (−13%), Quality Score 50/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of JVC calculated?
We run Japan Vietnam Medical Instrument JSC through 11 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,362 VND, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Japan Vietnam Medical Instrument JSC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Japan Vietnam Medical Instrument JSC (JVC)?
The closing price on Sep 24, 2026 was 2,720 VND. Our model-based fair value is 2,362 VND, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Japan Vietnam Medical Instrument JSC right now?
Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Japan Vietnam Medical Instrument JSC

How large is the market capitalisation of Japan Vietnam Medical Instrument JSC (JVC)?
The market capitalisation of Japan Vietnam Medical Instrument JSC is 371B VND. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Japan Vietnam Medical Instrument JSC (JVC)?
The price-to-sales ratio of Japan Vietnam Medical Instrument JSC is 0.50 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Japan Vietnam Medical Instrument JSC (JVC)?
Earnings per share at Japan Vietnam Medical Instrument JSC are −75.57 VND. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Japan Vietnam Medical Instrument JSC (JVC)?
The net margin of Japan Vietnam Medical Instrument JSC is −7.7% (fiscal year 2022). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Japan Vietnam Medical Instrument JSC (JVC)?
The return on equity (ROE) of Japan Vietnam Medical Instrument JSC is 6.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Japan Vietnam Medical Instrument JSC (JVC)?
On an EBIT basis the return on assets of Japan Vietnam Medical Instrument JSC is −6.7% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Japan Vietnam Medical Instrument JSC (JVC)?
The operating margin of Japan Vietnam Medical Instrument JSC is 11.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Japan Vietnam Medical Instrument JSC (JVC)?
Revenue at Japan Vietnam Medical Instrument JSC is growing −12.2% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Japan Vietnam Medical Instrument JSC (JVC)?
Earnings per share at Japan Vietnam Medical Instrument JSC are growing −53.5% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Japan Vietnam Medical Instrument JSC in the live analysis

One click puts Japan Vietnam Medical Instrument JSC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.